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Abstract 31 
Intersectin 1-short (ITSN1-s) is a 1220 amino acids ubiquitously-expressed scaffold protein 32 
presenting a multi-domain structure that allows to spatiotemporally regulate the functional 33 
interaction of a plethora of proteins. Beside its well-established role in endocytosis, ITSN1-s is 34 
involved in regulation of cell signaling and is implicated in tumorigenesis processes, although the 35 
signaling pathways involved are still poorly understood. Here we identify ITSN1-s as a 36 
nucleocytoplasmic trafficking protein. We show that, by binding to importin (IMP)D, a small 37 
fraction of ITSN1-s localizes in the cell nucleus at the steady state, where it preferentially associates 38 
with the nuclear envelope (NE) and interacts with lamin A/C. However, upon pharmacological 39 
ablation of Chromosome region maintenance 1 (CRM-1) dependent nuclear export pathway, the 40 
protein accumulates into the nucleus, thus revealing its moonlighting nature. Analysis of deletion 41 
mutants revealed that the coiled coil (CC) and Src homology (SH3) regions play the major role in 42 
its nucleocytoplasmic shuttling. While no evident nuclear localization signal (NLS) was detected in 43 
the CC region, a functional bipartite NLS was identified within the SH3D region of ITSN1-s 44 
(RKKNPGGWWEGELQARGKKRQIGW-1127), capable of conferring energy-dependent nuclear 45 
accumulation to reporter proteins and whose mutational ablation affects nuclear import of the whole 46 
SH3 region. Thus, ITSN1-s is an endocytic protein, which shuttles between the nucleus and the 47 
cytoplasm in a CRM-1 and IMPD dependent fashion.  48 
 49 
 50 
 51 
 52 
 53 
 54 
 55 
 56 
  57 
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Introduction 58 
 Scaffold proteins (scaffolds), are important components of several cellular processes and 59 
signaling systems. Usually, scaffolds are soluble proteins devoid of enzymatic activity, containing 60 
several modular protein-interaction domains within their structure, together with sites for inducible 61 
posttranslational modifications [1]. Scaffolds control the assembly of multiprotein complexes, thus 62 
contributing to localize signaling molecules to specific cell compartments or/and to regulate the 63 
efficiency of signaling pathways [2]. For example, Grb2-Associated Binding Protein 2 (GAB2) is 64 
involved in the assembly of signaling systems downstream of receptor tyrosine kinases and non-65 
receptor tyrosine kinases [3], while Shc proteins have roles in signaling via many different types of 66 
receptors, such as growth factor receptors, antigen receptors, cytokine receptors, G-protein coupled 67 
receptors, hormone receptors and integrins [4].  68 
 Accumulating evidence suggests that several cytoplasmic adaptor proteins involved in 69 
endocytosis, such as clathrin, adaptor protein containing a pleckstrin homology domain, 70 
phosphotyrosine-binding domain, and leucine zipper motif 1 (APPL1) and Beta arrestin1, are 71 
capable of shuttling between the nucleus and the cytoplasm, being involved in nuclear signaling and 72 
transcriptional events in response to extracellular signals [5-7]. Therefore, a detailed understanding 73 
of the cellular compartmentalization dynamics of adaptor proteins is crucial to gain insights 74 
regarding their function. 75 
 In eukaryotes, nucleocytoplasmic transport of cargoes larger than 50-60 kDa is a signal- and 76 
energy-dependent process, which takes place across aqueous channels, delimited by nuclear 77 
envelope (NE)-embedded nuclear pore complexes (NPCs). Members of the kariopherin 78 
superfamily, recognize specific nuclear targeting signals (NTSs) responsible for targeting cargoes 79 
either into or out of the nucleus, nuclear localization or nuclear export signals - NLSs and NESs - 80 
respectively [8]. Usually nuclear import is mediated by importins (IMPs), such as IMPE1 or one of 81 
its homologues, after recognition of cargo bearing NLSs, either directly or through the adaptor 82 
molecule IMPD. IMPD recognizes short basic NLSs - also named "classical" NLS (cNLS). cNLSs 83 
can be classified as monopartite - matching the consensus K-(K/R)-X-(K/R), or bipartite - matching 84 
the consensus: [(K/R)(K/R)–X10–12–(K/R)3/5], where X is any amino acid, and (K/R)3/5 represents 3 85 
lysine or arginine residues out of 5 consecutive amino acids. Subsequently, complexes are 86 
translocated through the NPCs into the nucleus, whereby binding of RanGTP to IMPE promotes 87 
their dissociation and cargo release [9].  88 
 On the other hand, proteins are exported from the nucleus by exportins such as Chromosome 89 
region maintenance 1 (CRM-1), the so far best characterized exportin. In the nucleus, RanGTP-90 
complexed CRM-1 recognizes cargoes bearing short NESs containing four non-consecutive 91 
4 
 
hydrophobic residues [10] and it translocates them to the cytoplasm, where RanGTP-CRM1-cargo 92 
complexes are dissociated and RanGTP is hydrolyzed to RanGDP and this allows CRM1 to be 93 
recycled back to the nucleus [11]. 94 
 Intersectin 1 (ITSN1) is a ubiquitously expressed scaffold protein present in a long and short 95 
isoform of 190 and 145 kDa respectively. ITSN1-s contains two N-terminal Eps15 homology (EH) 96 
domains, a coiled coil (CC) region, and five SRC homology 3 (SH3A-E) domains. Due to its 97 
multimodular architecture, it interacts with several proteins involved in clathrin- and caveolin-98 
mediated endocytosis, rearrangements of the actin cytoskeleton, cell signaling and survival [12, 13]. 99 
Indeed EH domains recognize the Asn-Pro-Phe (NPF) motif of many endocytic machinery proteins, 100 
including Epsin [14, 15] while the coiled coil (CC) region mediates protein dimerization and 101 
interacts with Eps15 and Eps15R [16], as well as with SNAP23, SNAP25 and HIP [17]. The SH3 102 
domains, typical of cytoskeleton proteins and proteins involved in signal transduction, recognize 103 
proline rich motifs of endocytic proteins such as Dynamin, Synapsin and Synaptojanin [18], as well 104 
as the SH3 domain of Endophilin [19].  105 
Analysis of HeLa nuclei phosphoproteome revealed the presence of peptides derived from ITSN1-s, 106 
suggesting that ITSN1-s could have access to the nucleus and play a role therein, similarly to other 107 
scaffold adaptor proteins [20]. 108 
 In the present study, we report that a small, but significant fraction of ITSN1-s is present at 109 
the steady state in the nucleus of HeLa and HEK 293 cells, where it accumulates on the NE. We 110 
show here for the first time that ITSN1-s is able to bind to IMPD and shuttle between the cytoplasm 111 
and the nucleus in a CRM-1 dependent fashion. We also identify a bipartite NLS located at residues 112 
1104-1127, capable of conferring energy and Ran dependent nuclear import abilities to a reporter 113 
protein.  114 
 115 
  116 
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Experimental 117 
 118 
Cell culture and transfections. HeLa, HEK 293-A and HEK 293-T cells were maintained in 119 
Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% (v/v) fetal bovine serum 120 
(FBS), 50 U/ml penicillin, 50 U/ml streptomycin and 2 mM L-glutamine as described previously 121 
[21-23]. For Confocal laser scanning microscopy (CLSM) experiments, 3 × 104 HEK 293-A or 2.5 122 
× 104 HeLa cells were seeded onto polylisinated 12 mm glass coverslips in 24-well plates 1 day 123 
before transfection using Lipofectamine 2000 (Thermofisher) according to the manufacturer's 124 
recommendations [24]. For live cell imaging experiments, 6 × 105 HeLa cells were seeded in a 125 
glass bottom 6-well plate (P06G-0-10F, MatTec) 1 day before transfection using Lipofectamine 126 
3000 (Thermofisher) according to the manufacturer’s recommendations. For cytosol/nucleus 127 
separation of endogenous and FLAG-ITSN1-s, and for immunoprecipitation between GFP-128 
IMPD'IBB and FLAG tagged fusion proteins 5 x 105 HeLa cells and HEK 293-T cells were 129 
seeded in 60 mm diameter dish the day before transfection using Lipofectamine 2000. All 130 
experiments were carried out 48 h post transfection. 131 
 132 
Plasmid construction. Mammalian expression plasmids were generated using the GatewayTM 133 
technology (Invitrogen). ITSN1-s regions of interest were amplified with appropriate primer pairs 134 
containing attB sites using plasmid FLAG-ITSN1-s [25] (a kind gift of Peter S. McPherson, 135 
McGill University, Montreal, Quebec, Canada) and cloned into plasmid vector pDNR207 136 
(Invitrogen) via BP recombination, to generate entry clones, as previously described [26]. Entry 137 
clones were then used to generate C-terminal YFP fusion Mammalian expression vectors 138 
following LR recombination reactions with the pDESTnYFP [27] Gateway compatible vector, as 139 
described previously [28]. All vectors were confirmed by sequencing. Point mutant derivatives 140 
carrying amino acid substitutions of ITSN-NLS (RKKNPGGWWEGELQARGKKRQIGW-1127, 141 
to aatNPGGWWEGELQARGatsQIGW-1127) were generated using appropriate oligo pairs and 142 
the Quikchange mutagenesis kit (Agilent technologies) as described previously [29]. As positive 143 
and negative controls for response to LMB treatment, plasmids GFP-Rev (2-116), encoding the 144 
Rev protein from HIV-1, which shuttles between nucleus and cytoplasm in a CRM-1 dependent 145 
manner, and GFP-UL44∆NLS driving the expression of an exclusively cytosolic version of human 146 
cytomegalovirus DNA polymerase processivity factor UL44, were used in addition to the pEGFP-147 
C1 (Clontech) expression vector [30, 31]. Plasmid pEGFP-C1-mIMPD'IBB, encoding a GFP-148 
tagged deletion mutant of mouse IMPD6 lacking the autoinhibitory IMPE binding (IBB) domain, 149 
therefore binding to cNLSs with high affinity [32], was described elsewhere [33]. pDESTnFLAG-150 
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UL44, a plasmid mediating expression of a FLAG-tagged version of UL44 which is known to be 151 
transported into the nucleus by the IMPD/E heterodimer, was used as a positive control in 152 
immunoprecipitation experiments with GFP-mIMPD'IBB [28]. Plasmid pDESTnYFP-NLS[R], 153 
encoding a fusion protein between YFP and a minimal cNLS derived from Simian Virus 40 Large 154 
Tumor antigen, mediating nuclear targeting via IMPDE was described elsewhere (Smith et al., 155 
unpublished observations). 156 
 157 
Confocal laser scanning microscopy (CLSM). HeLa cells were treated as described in [34]. 158 
Briefly, cells were washed with PBS, fixed with 4% paraformaldehyde (PFA) for 10 min at room 159 
temperature (RT), permeabilized with 0.2% TritonX-100, 2mg/ml BSA, 1mM NaN3 in PBS on ice 160 
three times for 10 min. Cells were subsequently incubated with blocking solution (0.02% TritonX-161 
100, 3% BSA, 1mM NaN3 in PBS). Primary antibodies D-FLAG (SIGMA), and D-lamin A/C 162 
(Thermo fisher) were incubated for 30 min in blocking solution and washed three times for 10 min 163 
with wash buffer (PBS 0.02% TritonX-100, 1.5% BSA, 1mM NaN3). Secondary antibodies (goat 164 
Dmouse Cy3, goat Drabbit Cy2, Jackson Immunoresearch) were incubated for 45 min and 165 
washed as described above. Coverslips were mounted using an antifade mounting medium 166 
(ProLong Gold-Invitrogen) on a glass slide. CLSM was performed on a ZEISS LSM 510 META 167 
confocal laser scanning microscope using the 63X or the 100X Plan-NEOFLUAR oil immersion 168 
objective. To analyze the subcellular distribution of spontaneously fluorescent fusion proteins 169 
expressed in  HEK 293-A cells, cells were transfected and, after 48 h, washed twice in PHEM 170 
buffer (60mM PIPES, 25mM HEPES, 10mM EGTA, and 4mM MgSO4) to preserve the cellular 171 
cytoskeleton [35], before being fixed with 3% PFA in PHEM buffer for 15 min at RT and mounted 172 
onto glass coverslips with FluoromountG (Southern Biotech). Samples were processed by CLSM 173 
using a Leica TCT-SP2 system, equipped with a Planapo fluor 63x oil immersion objective (Leica). 174 
At least 4 randomly chosen fields were acquired, and a total of at least 30 cells, expressing the 175 
fusion proteins of interest to similar levels, were analyzed for each repetition. The Fn/c values were 176 
determined using the NIH ImageJ 1.62 public domain software, from single cell measurements for 177 
each of the nuclear (Fn) and cytoplasmic (Fc) fluorescence, after the subtraction of fluorescence due 178 
to autofluorescence/background [36]. Data was plotted and statistically analyzed using Prism 6 179 
(GraphPad) software. 180 
 181 
Live Cell Imaging. HeLa cells were transfected to express the spontaneously fluorescent fusion 182 
protein of interest. 48h later, the medium was substituted with complete phenol red free DMEM 183 
(A18967, Life Technology). Cells were imaged with a DMi8 inverted microscope (Leica), 184 
7 
 
equipped with a 40x NA 0.6 objective, a motorized stage and a heated/humidified chamber, at 185 
37°C and 5% CO2. Several positions have been recorded for each sample. Phase contrast image 186 
served as reference for cytoplasm vs. nuclei masking. When required, the Fn/c values relative to 187 
each fusion protein were calculated as described above. 188 
 189 
Cell treatments. In indicated cases, Leptomycin B (LMB; Sigma L2913; 2.9 ng/ml) was added to 190 
cells 8 h before processing samples for imaging, as previously described [37]. Intracellular ATP 191 
was depleted by incubating cells for 2h at 37°C in DMEM lacking phenol red and glucose 192 
(Thermofisher), supplemented with 10 mmol/L sodium azide and 6 mmol/L 2-deoxy-D-glucose 193 
(Sigma), as described previously [38].  194 
 195 
Identification of putative NTSs on ITSN1-s. The primary sequences of ITSN1-s (NCBI 196 
Accession Number: NP_001001132.1) was scanned for putative NLS and NES using software 197 
programs cNLSmapper [38] and NES finder, respectively [39]. 198 
 199 
Western blot. Samples were heated in reducing SDS sample buffer (80 mM Tris, pH 6.8, 2% SDS, 200 
7.5% glycerol, 0.01% Bromophenol blue) supplemented with 2% 2-mercaptoethanol for 5 min at 95 201 
°C and separated by SDS–PAGE on acrylamide/bisacrylamide gels and analyzed by Western blot 202 
(WB) as previously described [21]. Briefly, samples were transferred for 1h onto PVDF membrane, 203 
blocked for 1h at 37°C with 5% fat free milk, 0.05% Tween-20 in PBS. PVDF membranes were 204 
incubated with specific antibodies: D-ITSN (Abcam), D-FLAG (SIGMA), D-lamin A/C (Thermo 205 
fisher), D-ERK 1/2 (Santa Cruz), anti-histone H3 (Santa Cruz), D-tubulin (Santa Cruz), or D-206 
GFP/GST (a generous gift from Prof. Hӧning, University of Cologne) overnight in PBS Tween 207 
0.05% + 1% fat free milk. The membrane was washed 3 times for 10 min with PBS Tween 0.05% 208 
and incubated 1h with one of the following secondary antibodies horseradish peroxidase-209 
conjugated: goat D-mouse and goat D-rabbit (Bethyl), rabbit D-goat (Pierce). Blots were detected 210 
using Immobilon Western Classico or Forte (Millipore). Images were acquired using a G:Box 211 
Chemi XT Imaging system (Syngene)[40]. 212 
 213 
Co-immunoprecipitation of protein complexes. HeLa or HEK 293-T cells were washed with PBS 214 
1X and harvested 48 h post transfection as described in [41]. Cells were centrifuged at 800 g for 10 215 
min and pellet was resuspended in ice cold lysis buffer, 50 mM Hepes, 100 mM NaCl, 1% NP-40 + 216 
Protease inhibitors cocktail [(PI), 1:1000 (Roche)] for 10 min on ice. Cells were then sonicated at 217 
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15% of instrument power (Sonopuls, Bandelin) for 10 sec. After clarification, supernatants were 218 
incubated with 4 μg of the DITSN, DLamin, D-FLAG antibodies or without antibody as negative 219 
control as indicated, overnight at 4 °C, with gentle rocking. The following day, 50 μL of protein 220 
A/G beads (Santa Cruz Biotechnology) were added and the mixtures incubated for 4 h. After 3 221 
washes with PBS 1X, beads were resuspended in SDS sample buffer for 5 min at 95 °C and 222 
centrifuged at 800 g for 3 min before the supernatant were collected. For immunoprecipitation of 223 
GFP-mIMPaDIBB in the presence of FLAG-ITSN1-s or not, the protocol has been adapted from 224 
[42]. HEK 293-T cells were washed with PBS 1X and harvested 48 h post transfection. Cells were 225 
centrifuged at 800 g for 10 min and pellet was resuspended in ice cold lysis buffer, 50 mM Hepes, 226 
100 mM NaCl, 1mM MgCl2, 1% NP-40 + Protease inhibitors cocktail [(PI), 1:1000 (Roche)] for 10 227 
min on ice. Cells were then sonicated as described above. After clarification, supernatants were 228 
incubated with 4 μg of the D-FLAG as indicated, overnight at 4 °C, with gentle rocking. The 229 
following day, 50 μL of protein A/G beads were added and the mixtures incubated for 4 h. After 3 230 
washes with 50 mM Hepes, 100 mM NaCl, 1mM MgCl2, 1% NP-40, beads were resuspended in 231 
SDS sample buffer and treated as described above. Samples were subjected to SDS-PAGE/WB 232 
analysis. 233 
 234 
Subcellular fractionation. In order to separate nuclei from cytoplasm a protocol from Nabbi et al. 235 
has been adapted [43]. Briefly, HeLa cells grown to 90% confluency in 10 cm dishes were washed 236 
with ice cold PBS and scraped. Cells were centrifuged at 10000 g for 10 sec. Cell pellets were 237 
resuspended in PBS with 0.1% NP-40 and triturated with a P1000 micropipette. The lysed cells 238 
suspension was centrifuged at 10000 g for 10 sec. The supernatant representing the cytoplasmic 239 
fraction was isolated, the nuclei were gently resuspended in PBS with 0.1% NP-40 and centrifuged 240 
again. Nuclear pellet was resuspended in SDS sample buffer and sonicated twice at 15% of 241 
instrument power (Sonopuls, Bandelin) for 6 sec on ice. Fractions were analyzed by SDS-242 
PAGE/WB as described above. 243 
 244 
Nucleoplasm/Nuclear envelope separation. To separate nucleoplasm and nuclear envelope, nuclei 245 
obtained as described above were resuspended in NP-40 buffer (PBS 0.5X, 10 mM MgCl2, 50 mM 246 
MOPS pH 7.4, 0.5% NP-40, DNAase 5 U/mL, PI 1:1000, and incubated on ice 5 min. Samples 247 
were centrifuged at 20000 g for 10 min and supernatants were collected and considered as 248 
nucleosol. Pellet (nuclear envelope) were resuspended in RIPA buffer (150 mM NaCl, 1% NP-40, 249 
50 mM Tris-HCl pH 8, 0.1% SDS, 0.5% Sodium desossicolate, PI) and tip-sonicated 12 sec at 15% 250 
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of instrument power (Sonopuls, Bandelin). Fractions were analyzed by SDS-PAGE/WB as 251 
described above. 252 
 253 
Chemical crosslinking to detect DNA-binding proteins. In order to visualize if ITSN1-s is a 254 
DNA binding protein a protocol from Qiu et al [44] has been adapted. HeLa cells (10 cm dish, 90% 255 
confluency) were trypsinized and collected by centrifugation at 300 g for 5 min at 4 °C. Cells were 256 
washed with ice-cold PBS to remove culture medium and FBS. In vivo cross-linking was achieved 257 
by adding PFA to 1 mL of cell suspension in PBS to obtain a final concentration of 1% (w/v). After 258 
incubating at RT, PFA was quenched by glycine to a final concentration of 125 mM and incubated 259 
at RT for 5 min. The cross-linked cells were collected by centrifugation (300 g at 4 °C for 5 min), 260 
and the cell pellet was washed twice with cold PBS. Nuclei isolation was carried out using a 261 
protocol adapted from that reported by Henrich et al. [45, 46]. The cross-linked HeLa cell pellet (2x 262 
10 cm dishes, 70% confluent) was resuspended in 10 volumes of ice-cold hypotonic lysis buffer A 263 
containing 10 mM HEPES (pH 7.4), 10 mM KCl, 1.5 mM MgCl2, 1 mM DTT, and PI 1:1000. After 264 
incubation on ice for 30 min, 0.5% (v/v) NP-40 was added to the lysis buffer. Cells were then 265 
gently lysed with a Dounce homogenizer and the nuclear fraction was collected by centrifugation. 266 
The nuclear fraction resuspended in buffer B (250 mM sucrose, 10 mM MgCl2, 20 mM Tris-HCl 267 
(pH 7.4) and 1 mM DTT) was layered over a two-step sucrose gradient cushion [1.3 M sucrose, 268 
6.25 mM MgCl2, 20 mM Tris-HCl (pH 7.4), 0.5 mM DTT above 2.3 M sucrose in 2.5 mM MgCl2 269 
and 20 mM Tris-HCl (pH 7.4)] and centrifuged subsequently at 19000g at 4 °C for 45 min. The 270 
isolated nuclei were washed with buffer A and collected by centrifugation at 1000g.  271 
Isolation of DNA-Protein Complexes, cross-Linking Reversal and DNA Removal were performed 272 
as described previously [44]. The purified DNA-binding proteins were separated using a NuPage 4-273 
12% Bis-Tris protein gel (Invitrogen). 274 
 275 
Statistical analysis. Statistically significant differences between datasets were determined with 276 
Student’s t-Test (Graphpad software, Inc.). P values of less than 0.05 were considered statistically 277 
significant with *p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001. Values shown are the mean ± standard error 278 
of the mean (SEM) relative to at least three independent experiments [47, 48]. 279 
  280 
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Results 281 
 282 
A fraction of ITSN1-s localizes to the nucleus 283 
In order to investigate ITSN1-s subcellular localization, HeLa cells were transfected with a FLAG-284 
ITSN1-s expression plasmid and subjected to biochemical separation of nuclear and cytosolic 285 
fractions. Mock-transfected cells were used as a negative control. Then, ITSN1-s distribution was 286 
analyzed in the two fractions by SDS-PAGE/WB. ERK1/2 and lamin A/C were used as reference 287 
proteins for cytosolic and nuclear compartments, respectively. Both FLAG-tagged and 288 
endogenous ITSN1-s were enriched in the cytosol, but detectable in both fractions, while reference 289 
proteins were localized exclusively in the specific fraction, proof of a clean compartment 290 
separation (Fig. 1A). We also confirmed our results by immunofluorescence (IF), limiting our 291 
analysis to FLAG-ITSN1-s due to the lack of suitable commercial antibodies. The protein 292 
presented mainly a cytoplasmic localization, although it was also visible in the cell nucleus (Fig. 293 
1B). Thus, our data demonstrate the existence of a nuclear pool of ITSN1-s.  294 
 295 
ITSN1-s is enriched in the nuclear envelope 296 
The relative amount of nuclear FLAG-ITSN1-s detectable in the nucleus after subcellular 297 
fractionation appears higher than that observable by IF (Fig. 1), raising the possibility that the 298 
majority of nuclear FLAG-ITSN1-s is associated to the nuclear envelope (NE) rather than in the 299 
nucleoplasm. To verify this hypothesis, nucleoplasmic and NE fractions from purified nuclei of 300 
HeLa cells transfected to express FLAG-ITSN1-s were analyzed by SDS-PAGE/WB to detect the 301 
cytosolic marker ERK1/2, the NE marker lamin A/C, as well as FLAG-ITSN1-s. As expected, 302 
while ERK1/2 was not detectable in the nuclear fraction, lamin A/C localized exclusively in the 303 
NE fraction (Fig. 2A). FLAG-ITSN1-s was both detectable in the nucleoplasmic and the NE 304 
fractions, but highly enriched in the latter, consistent with the idea that ITSN1-s could associate 305 
with the NE. IF analysis revealed that FLAG-ITSN1-s partially colocalizes with lamin A/C on the 306 
NE (Fig. 2B). Subsequently, we investigated the interaction between ITSN1-s and lamin A/C by 307 
co-immunoprecipitation (co-IP) analysis. HeLa cells were lysed, and ITSN1-s complexes pulled 308 
down using either an D-ITSN or an D-lamin A/C antibody. SDS-PAGE/WB analysis revealed the 309 
presence of two bands corresponding to lamin A and C in the ITSN1-s pull down lane and of a 310 
ITSN1-s band in the lamin A/C pull down (Fig. 2C).  311 
Finally, since some endocytic proteins were found to be part of transcription complexes [49], we 312 
tested the possibility that ITSN1-s could bind DNA. To this end, we adapted a protocol which 313 
includes chemical cross-linking of cells followed by nuclei isolation and purification of covalently 314 
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bound DNA-protein complexes [44]. DNA protein complexes were isolated and analyzed by a 315 
SDS-PAGE/WB using D-ITSN1, in addition to D-tubulin and D-Histone H3 antibodies as negative 316 
and positive controls, respectively [50]. As expected, Histone H3 was detectable in the DNA 317 
protein complexes lane (DPC) as well as in the cell homogenate (H), whereas tubulin, which is 318 
incapable of binding to DNA, was detectable only in the cell homogenate (Fig. 2D). Importantly 319 
FLAG-ITSN1-s could not be detected in the DPC, suggesting that ITSN1-s does not interact with 320 
cellular DNA. Taken together our results indicate that a small, but detectable amount of ITSN1-s 321 
localizes within the cell nucleus at the steady state, where it preferentially associates with the NE, 322 
possibly interacting with lamin A/C.  323 
 324 
ITSN1-s interacts with IMPD  325 
The fact that a certain fraction of the 145 kDa protein ITSN1-s can gain access to the nucleus 326 
implies the protein is actively translocated into the nucleus in a NLS-dependent fashion by IMPs. 327 
A bioinformatics analysis using the NLS prediction software “cNLS MAPPER” revealed the 328 
presence of a putative bipartite cNLS (RKKNPGGWWEGELQARGKKRQIGW-1127), located 329 
in the C-terminal, SH3 portion of ITSN1-s (Fig. 3A,B). Such sequence strongly resembles the 330 
prototype bipartite cNLS originally described on nucleoplasmin (KRPAATKKAGQAKKKK-331 
170) and perfectly matches the consensus for such signals. This finding raised the possibility that 332 
ITSN1-s could bind to the IMPD/E heterodimer. To assess this hypothesis by co-IP experiments, 333 
HEK 293-T cells were transfected to express GFP-IMPD'IBB either individually or in the 334 
presence of FLAG-ITSN1-s. The former is a GFP-tagged derivative of IMPDthat lacks the 335 
autoinhibitory IMPE binding (IBB) domain, and that therefore binds to NLSs with an affinity 336 
comparable to that of the IMPD/E heterodimer [32]. As a positive control, GFP-IMPD'IBB was 337 
also expressed in the presence of FLAG-UL44, a protein known to be recognized by the IMPD/E 338 
heterodimer [28]. Proteins were subsequently immunoprecipitated in the presence or in the 339 
absence of the FLAG antibody. As expected, FLAG-UL44 could be co-immunoprecipitated with 340 
GFP-IMPD'IBB, whereas no GFP-IMPD'IBB was obtained after incubation of cell lysates in the 341 
absence of the DFLAG antibody, indicating that GFP-IMPD'IBB did not interact unspecifically 342 
with protein A/G beads (Fig. 4A). Importantly, GFP-IMPD'IBB could be also co-343 
immunoprecipitated by the DFLAG antibody from cells co-expressing FLAG-ITSN1-s, but not 344 
from cells expressing GFP-IMPD'IBB alone, indicating that GFP-IMPD'IBB did not interact 345 
unspecifically with the DFLAG antibody (Fig. 4B). Taken together these results show that 346 
ITSN1-s is able to interact with IMPD, thus being actively transported into the nucleus. 347 
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  348 
ITSN1-s is a nucleocytoplasmic trafficking protein 349 
Despite its ability to bind to IMPD, at the steady state ITSN1-s preferentially localizes in the 350 
cytosol. It is therefore possible that, as described for other endocytic proteins [6], ITSN1-s shuttles 351 
between the nucleus and the cytoplasm thanks to the simultaneous presence of NLS and NES. A 352 
bioinformatics analysis using the NES prediction software “NES finder”, integrated by visual 353 
inspection based on a systematic analysis of NES consensus performed in eukaryotic cells [10], 354 
identified 6 putative hydrophobic rich NESs [NES A-F] distributed throughout the 3 regions of 355 
ITSN1-s (EH-like homology; EHs, aas 1-380; coiled coil; CC, aas 381-680 and; SH3s, aas 681-356 
1220) (Fig. 3A,B). The presence of putative hydrophobic NESs within ITSN1-s indeed suggested 357 
that the protein could undergo nucleocytoplasmic shuttling in a CRM-1 dependent manner. 358 
In order to confirm this hypothesis, the subcellular localization of ITSN1-s was tested in HeLa 359 
cells upon LMB-mediated inhibition of CRM1 activity. FLAG-ITSN1-s transiently transfected 360 
cells were treated or not with LMB, before CLSM analysis to quantify their levels of nuclear 361 
accumulation. In addition to FLAG-ITSN1-s, cells were also transfected with GFP, GFP-Rev, a 362 
protein known to accumulate in the nucleus after LMB treatment, as well as with GFP-363 
UL44'NLS, a Ү 180 kDa dimeric cytosolic protein which is excluded from the nucleus due to the 364 
lack of a functional NLS. Addition of LMB did not affect the subcellular localization of either 365 
GFP and GFP-UL44'NLS, implying the treatment did not affect cell viability and morphology as 366 
well as NPC permeability, while it caused GFP-Rev to strongly accumulate in the cell nucleus 367 
(Fig. S1 and Table S1). Importantly, after treatment with LMB, FLAG-ITSN1-s nuclear staining 368 
became significantly more evident (Fn/c from 0.15 to 0.45), although the protein did not 369 
accumulate in the cell nucleus to high levels (Fig. 5A,B and Table S2). Thus, ITSN1-s can shuttle 370 
between the nucleus and the cytosol in a IMPD/E and CRM1-dependent fashion. 371 
 372 
ITSN1-s CC and SH3 regions can independently undergo nucleocytoplasmic shuttling. 373 
In an effort to identify ITSN1-s functional NTSs among the putative ones predicted, we generated 374 
several ITSN1-s deletion mutants fused to the C-terminus of YFP. We initially verified that 375 
addition of a YFP-tag did not interfere with ITSN1-s subcellular localization and 376 
nucleocytoplasmic shuttling abilities. To this end, HeLa cells were transfected to express YFP-377 
ITSN1-s, whose subcellular localization was initially monitored by live cell imaging every min for 378 
a period of 30 min. As expected, YFP-ITSN1-s localized mainly in the cytoplasm, with evident 379 
dots reminiscent of endocytic vesicles, which appeared to be highly mobile (Fig. S2 and Mov. S1). 380 
In a second series of experiments, HeLa cells were transfected to express either YFP-ITSN1-s or 381 
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GFP-UL44'NLS, treated with either LMB or with solvent, and the subcellular localization of the 382 
fusion protein of interest visualized every 15 min for 10 h. As expected, YFP-ITSN1-s gradually 383 
accumulated into the nucleus, reaching a maximum approximately 5 h after LMB addition, 384 
whereas the negative control GFP-UL44'NLS remained mainly cytosolic for the whole duration 385 
of the experiment (Fig. S3 and Mov. S2). Therefore, YFP-ITSN1-s could be used to study the 386 
nucleocytoplasmic properties of ITSN1-s. Beside full length ITSN1-s (1-1220), we generated 387 
plasmids mediating the expression of five additional deletion mutants: YFP-ITSN1-s-ΔEHs (316-388 
1220), lacking the N-terminal epsin like domain; YFP-ITSN1-s-ΔSH3s (1-680), lacking the C-389 
terminal SH3 domains; YFP-ITSN1-s-SH3s (681-1220); YFP-ITSN1-s-EHs (1-315) and YFP-390 
ITSN1-s-CC (316-680) (Fig. 6A). As a first step towards the characterization of such variants, 391 
their molecular weights were verified by SDS-PAGE/WB using an D-GFP antibody (Fig. 6B). 392 
Fusion proteins migrated at the expected molecular weights (YFP-ITSN1-s: 160 kDa, YFP-393 
ITSN1-s-ΔEHs: 125kDa, YFP- ITSN1-s-ΔSH3s: 101 kDa, YFP-ITSN1-s-SH3s: 85 kDa, YFP-394 
ITSN1-s-EHs: 61 kDa, YFP-ITSN1-s-CC: 66 kDa). Multiple bands of higher molecular weight 395 
could be detected for the YFP-ITSN1-s-CC fusion, most likely due to protein 396 
multimerization/aggregation. Secondly, we decided to investigate their subcellular localization 397 
either in the absence or in the presence of LMB. HEK 293-A cells were transiently transfected 398 
with appropriate expressing vectors and the subcellular localization of YFP-ITSN1-s was 399 
compared by quantitative CLSM to that of the above described deletion mutants. Along with YFP-400 
ITSN1-s fusions, the previously described controls (GFP, GFP-Rev and GFP-UL44ΔNLS) were 401 
used to verify the functionality of LMB treatment (Fig. 6C). As expected, GFP evenly distributed 402 
between nucleus and cytoplasm both in absence and presence of LMB (Fn/c 1.27 + 0.14 vs 1.50 + 403 
0.28). Similarly, GFP-UL44ΔNLS, having a molecular weight a Ү 180 kDa, was retained in the 404 
cytosol in both cases (Fn/c 0.10 + 0.09 vs 0.17 + 0.08). Importantly, LMB addition significantly 405 
enhanced nuclear accumulation of GFP-Rev (Fn/c 0.16 + 0.03 vs 16.97 + 9.87), which strongly 406 
accumulated in the nucleoli. Taken together, our data indicate that LMB treatment functionally 407 
inhibited CRM-1 mediated nuclear export without affecting NE permeability (see Fig. 6C,D, left 408 
panel and Table S3). As expected, in the absence of LMB, YFP-ITSN1-s mainly localized in the 409 
cytoplasm of untreated cells (Fig. 6C and Fig. 2D, right panels and Table S4; Fn/c 0.11 ± 0.08) 410 
with a punctuate pattern present in the cytoplasm and in close proximity to the plasma membrane, 411 
thus resembling that of endocytic vesicles. Deletion of EH domains (YFP-ITSN1-s-ΔEH) altered 412 
ITSN1-s localization pattern, in that the punctuate structures observed for FL-ITSN1-s were not 413 
detectable, and large protein aggregates were often present in strongly expressing cells. However, 414 
the protein was still mainly detectable in the cytoplasm (Fn/c 0.07 + 0.04). Removal of both EH 415 
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and CC regions (YFP-ITSN1-s-SH3s), caused the protein to localize in the cytosol with a mainly 416 
diffuse pattern, although a few vesicle-like dots were still detectable (Fn/c 0.10 + 0.04). On the 417 
contrary, removal of ITSN1-s SH3 region (YFP-ITSN1-s-ΔSH3s) did not change the punctate 418 
pattern described for ITSN1-s but caused a significant increase of nuclear signal (Fn/c 0.42 + 419 
0.09). When both the CC and SH3 regions were simultaneously deleted (YFP-ITSN1-s-EHs), the 420 
subcellular localization was completely altered: this protein equally distributed between the 421 
nucleus and the cytoplasm with a diffuse pattern (Fn/c 1.13 + 0.35). In addition, vesicle-like dots 422 
or protein aggregates were not detectable. Finally, YFP-ITSN1-s-CC fusion, devoid of both EH 423 
and SH3 regions, localized mainly in the cytoplasm, but entered the nucleus slightly more 424 
efficiently with respect to YFP-ITSN1-s (Fn/c 0.24 + 0.08). The protein distributed with a diffuse 425 
pattern in the cytoplasm, with the presence of large protein aggregates in the cytosolic 426 
compartment of highly expressing cells.  427 
 Importantly, addition of LMB increased nuclear levels of YFP-ITSN1-s (Fn/c 0.11 + 0.08 428 
vs 0.41 + 0.11), as well as of all YFP-ITSN1-s deletion mutants, apart from YFP-ITSN1-s-EHs 429 
(Fn/c 1.13 + 0.35 vs 1.34 + 0.32, see Fig. 6C,D). Indeed, both ITSN1-s-CC and ITSN1-s-SH3 430 
responded to LMB treatment (Fn/c of 0.24 vs. 0.72 and 0.10 vs 0.78, respectively) similarly to 431 
ITSN1-s-ΔEH and ITSN1-s-ΔSH3 (Fn/c of 0.07 vs. 0.32 and 0.42 vs 1.32, respectively). 432 
Therefore, both ITSN1-s CC and SH3 regions were sufficient to confer LMB-dependent 433 
nucleocytoplasmic shuttling properties to YFP. Taken together, the subcellular localization of 434 
ITSN1-s and its deletion mutants at the steady state suggest that the N-terminal EH domain (to a 435 
larger extent) and the C-terminally located SH3 regions play a role in ITSN1-s localization to 436 
endocytic vesicles-like dots, while the CC domain can cause protein aggregation, when expressed 437 
outside the physiological context of FL-ITSN1-s. In addition, LMB experiments suggest that 438 
ITSN1-s could contain multiple NTSs located in the CC and SH3 regions, whereas ITSN-EH 439 
domain does not actively contribute to the protein's nucleocytoplasmic shuttling ability, and NESs 440 
[A-C] are not functional in terms of mediating CRM-1 dependent nuclear export. 441 
 442 
ITSN1-s residues 1104-1127 represent a functional cNLS. As a first attempt towards the 443 
characterization of ITSN1-s nucleo-cytoplasmic shuttling process, we decided to identify its NLS. 444 
Our bioinformatics analysis could not detect any cNLS in ITSN1-s-CC region, but revealed the 445 
presence of a putative bipartite cNLS in the SH3 region, within ITSN1-s-SH3D domain 446 
(RKKNPGGWWEGELQARGKKRQIGW-1127) (Fig. 3). To validate its functionality, we 447 
generated an expression plasmid encoding such sequence C-terminally fused to YFP (YFP-448 
ITSN1-s-NLS) and analyzed the ability of the YFP-ITSN1-s-NLS fusion protein to accumulate in 449 
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the nucleus in an energy-dependent manner. We also analyzed the subcellular localization of YFP 450 
alone or of the control YFP-NLS[R] fusion protein, known to localize to the cell nucleus through 451 
interaction with the IMPD/E heterodimer (Smith et al., unpublished observations). As expected, 452 
when cells were maintained in normal media, YFP-NLS[R] accumulated into the nucleus of 453 
transfected cells (Fn/c 2.8) in significantly higher levels than YFP alone (Fn/c 1.1; Fig. 7 and 454 
Table S5). Depletion of intracellular ATP significantly decreased the nuclear accumulation of 455 
YFP-NLS[R], without affecting the subcellular localization of YFP alone (Fn/c of 1.5 and 1.1 456 
respectively; Fig. 7). Importantly, YFP-ITSN1-s-NLS accumulated into the nucleus at 457 
significantly higher levels as compared to YFP alone when cells were maintained in normal media 458 
(Fn/c 1.8), and its nuclear accumulation was significantly impaired after incubation in the energy 459 
depletion media (Fn/c 1.3). These data clearly show that ITSN1-s residues 1104-1127 represent a 460 
basic NLS capable of conferring energy dependent nuclear localization to heterologous proteins. 461 
 462 
ITSN-NLS is essential for nuclear targeting of ITSN1-s C-terminal domain. We decided to test 463 
the impact of ITSN1-s-NLS on nuclear targeting of the protein. We compared the subcellular 464 
localization of YFP-ITSN1-s to that of its derivative YFP-ITSN1-sΔNLS, where basic residues of 465 
its NLS (RKKNPGGWWEGELQARGKKRQIGW-1127) were substituted with hydrophobic ones 466 
(ΔNLS; aatNPGGWWEGELQARGatsQIGW-1127; see Fig. 8A), either in the absence or in the 467 
presence of LMB. Under both conditions, the NLS defective derivative localized with a very similar 468 
pattern as compared to the wild-type protein (Fig. 8B). This was not surprising, since deletion of the 469 
whole ITSN1-s-SH3 region, comprising ITSN1-s-NLS, did not impair the ability of the protein to 470 
enter the nucleus upon LMB treatment, implying a contribution of ITSN1-s-CC region in 471 
nucleocytoplasmic shuttling of ITSN1-s (Fig. 6). In order to study the contribution of ITSN1-s-NLS 472 
to nuclear import of the protein independently of the contribution of ITSN1-s-CC region, we 473 
analyzed the subcellular localization of a series of ITSN1-s C-terminal domain deletions, including 474 
YFP-ITSN1-s-SH3s, encompassing residues 681-1220; YFP-ITSN1-s-SH3(A-D) comprising 475 
residues 681-1173; and YFP-ITSN1-s-SH3(D-E) comprising ITSN1-s residues 1074-1220, either 476 
carrying the wild-type or the mutated NLS (Fig. 8). In the absence of LMB both YFP-ITSN1-s-SH3 477 
and YFP-ITSN1-s-SH3(A-D) localized mainly in the cytosol, and inactivation of ITSN-NLS did not 478 
affect the proteins subcellular localization (Fn/c c. 0.2, see Fig. 8). Upon LMB treatment, both YFP-479 
ITSN1-s-SH3 and YFP-ITSN1-s-SH3(A-D) significantly accumulated into the nucleus (Fn/c of c. 480 
0.8 and 1.1, respectively), while their NLS mutated counterparts were mainly retained in the cytosol 481 
(Fn/c of c. 0.4), clearly showing the importance of ITSN1-s residues 1104-1127 for nuclear 482 
targeting. The contribution of ITSN1-s-NLS to nuclear import was even more evident when 483 
16 
 
analyzing the subcellular localization of YFP-ITSN1-s-SH3(D-E). In absence of LMB, this protein 484 
was detectable in the nucleus, compatible with its ability to passively enter the nucleus by passive 485 
diffusion (Fn/c 0.9), while addition of LMB increased its nuclear accumulation (Fn/c 1.5). 486 
Importantly, in the absence of LMB, YFP-ITSN1-s-SH3(D-E)ΔNLS localized to the nucleus to 487 
lower levels (Fn/c of 0.5) as compared to its NLS bearing counterpart, further confirming the 488 
importance of ITSN1-s-NLS in nuclear import of the protein (Fig. 8B,C and Table S6). Overall our 489 
data also suggest that ITSN1-s-NESE -located within SH3D domain - is the functional NES within 490 
the SH3 region, while NESF - located within SH3E domain- does not contribute to CRM-1 nuclear 491 
export. Indeed, both YFP-ITSN1-s-SH(A-D) and YFP-ITSN1-s-SH3(D-E), accumulate to the 492 
nucleus in the presence of LMB. Furthermore, site specific mutagenesis for NESF did not abolish 493 
LMB responsiveness, nor increased steady state nuclear localization either in the SH3(A-E) or 494 
SH3(D-E) context (data not shown). However, attempts to mutate NESE hydrophobic residues 495 
resulted in increased nuclear accumulation in the presence of LMB (data not shown), probably by 496 
interfering with the nearby-located NLS, thus precluding formal proof that NESE is a functional 497 
NES.  498 
 499 
ITSN1s-CC shuttles between the nucleus and the cytoplasm independently of the presence of 500 
putative NTSs. Our data indicate that ITSN1-s-CC is capable of nucleocytoplasmic shuttling. 501 
However, no evident NTSs are present within its sequence, with the exclusion of a stretch of aa 502 
containing four L residues, which could resemble the NES originally described on HIV-1 Rev 503 
(NESD: LELEKQLEKQREL-419, see Fig. 3). Since NESD is located at the N-terminal portion of 504 
the CC region, we decided to test its functionality by analyzing the subcellular localization of the N-505 
terminal (residues 316-456, containing NESD) and of the C-terminal (residues 457-680) portions of 506 
ITSN1-s CC region, either in the absence or in the presence of LMB (Fig. 9A,B,C and Table S7). 507 
Strikingly, in the absence of LMB both YFP-ITSN1-s(316-456) and YFP-ITSN1-s(457-680) mainly 508 
localized in the cytosol of transfected cells, (Fn/c of 0.7 and 0.3, respectively) but accumulated in 509 
the nucleus upon LMB treatment (Fn/c of 1.4 and 1.2, respectively). Surprisingly, mutation of 510 
ITSN1-s-NESD hydrophobic residues (LELEKQLEKQREL-419 to qEaEKQqEKQREL-419), did 511 
not affect protein subcellular localization either in the absence or in the presence of LMB. 512 
Therefore, ITSN1-s-CC appears capable of shuttling between nucleus and cytosol in the absence of 513 
evident NTSs.  514 
 515 
 516 
Discussion 517 
 518 
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In the present work we showed for the first time that the adaptor scaffold protein ITSN1-s, known 519 
to be involved in several signaling and endocytic processes [1, 13, 51], and interacting with a 520 
plethora of factors involved in endocytosis, cytoskeleton rearrangements, cell signaling and survival 521 
[52-54], is a nucleocytoplasmic shuttling protein, which accumulates in the cell nucleus upon 522 
pharmacological ablation of CRM1-dependent nuclear export. At the steady state, a fraction of 523 
ITSN1-s localizes at the nucleus and is enriched at the nuclear envelope, where it interacts with 524 
lamin A/C.  525 
The identification of ITSN1-s nucleocytoplasmic shuttling sequences has been hampered by the 526 
evidence that both ITSN1-s CC and SH3 regions can shuttle between nucleus and cytosol 527 
independently of each other (Fig. 6). Moreover, the ITSN-1s CC region is apparently devoid of 528 
evident NTSs, bearing no putative cNLSs and only one putative leucine-rich NES (NESD: 529 
LELEKQLEKQREL-419), whose mutation to qEaEKQqEKQREL-419 did not affect LMB 530 
responsiveness (Fig. 9). Therefore, it is not known how ITSN-1s CC could undergo cytoplasmic 531 
shuttling. One possibility is that the D-helix rich CC domain can interact with the FG repeats of the 532 
NPC to allow passage in and out of the nucleus, in analogous fashion as it has been demonstrated 533 
for HEAT repeats containing proteins such as IMPE [55]. Another possibility is that one of the 534 
several cellular proteins capable of interacting with ITSN1-s-CC region, is responsible for transport 535 
across the NPCs through a “piggy-back” mechanism. Such proteins include the nucleocytoplasmic 536 
shuttling Eps15 and HIP1 proteins, as well as endogenous ITSN1-s, ITSN1-L and ITSN2-s  [16, 17, 537 
56-58]. Despite the confounding effect due to the presence of the CC-region, we were able to 538 
clearly demonstrate the existence of a functional bipartite cNLS in the SH3 region of ITSN1-s 539 
(ITSN1-s-NLS: RKKNPGGWWEGELQARGKKRQIGW-1127). ITSN1-s-NLS is capable of 540 
conferring ATP dependent nuclear targeting to YFP (Fig.7), and mutation of its basic residues 541 
impairs nuclear targeting of several YFP-ITSN1-s SH3 deletion mutants in the presence of LMB 542 
(Fig. 8). However, mutation of ITSN1-s-NLS in the context of the full length protein does not 543 
abolish its ability to enter the nucleus, most likely due to the fact that the CC region can mediate 544 
nuclear import and that deletion of the SH3 region of ITSN1-s similarly does not abolish the 545 
protein's nucleocytoplasmic shuttling properties (see Fig. 6). The bipartite nature of the ITSN1-s-546 
NLS was confirmed by CLSM quantitative analysis showing that deletion of upstream basic cluster 547 
alone only partially affected nuclear accumulation as compared to mutation of both clusters, in the 548 
context of the YFP-ITSN1-s-SH3(D-E) fusion protein (not shown), implying that both basic 549 
stretches of aa are required for optimal NLS activity [59].  550 
 Similarly to ITSN1-s, several endocytic adaptor proteins undergo nucleocytoplasmic 551 
trafficking, mainly to perform additional, specialized tasks within the nucleus, thus being dubbed 552 
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"moonlighting" proteins [56, 60-62]. A number of moonlighting proteins, such as Paxilin and EHD2 553 
migrate to the nucleus to regulate cellular proliferation and transcription processes [63, 64]. Our 554 
data, showing that ITSN1-s concentrates on the NE, where it interacts with lamin A/C (Fig. 2A-C), 555 
and does not bind to cellular DNA (Fig. 2D), rather suggest the possibility that ITSN1-s might play 556 
a role at the NE. It has been recently shown that a fourth endosomal route, besides recycling 557 
endosomes, endolysosomes or Golgi apparatus, transports cell surface receptors to the nucleoplasm 558 
through docking and membrane fusion of a population of endosomes with the nuclear envelope 559 
[65]. Such Nuclear Envelope Associated Endosomes (NAE) route may be an alternative mechanism 560 
by which external stimuli can influence cellular activity independently of the conventional signaling 561 
cascades that operate in the cytosol, and ITSN1-s could therefore be a new player in such route, 562 
helping to transport molecules from the plasma membrane to the nucleoplasm, as it has been 563 
hypothesized for Epidermal Growth Factor Receptor. It is very likely that this process comprises a 564 
series of tightly regulated events, hence experiments to unravel the mechanisms regulating ITSN1-s 565 
shuttling to the nucleus are undergoing in our laboratories. Furthermore, we do not exclude that the 566 
process of nuclear localization might be dependent on cell cycle phase, as it happens for other 567 
proteins [6, 66-68]. 568 
 Since modifications of the endocytic process have been recently linked to malignancy [69, 569 
70], it is likely that rerouting of endocytic proteins to other pathways or compartments due to 570 
moonlighting functions could be functionally linked to tumorigenesis. In this context, a very recent 571 
study showed that APPL1 and APPL2, Rab5 effector proteins and multifunctional adaptors 572 
containing different domains, implicated in several signaling pathways, and recently discovered as 573 
nucleocytoplasmic shuttling proteins [49], are required for the nuclear translocation of type I 574 
serine/threonine kinase receptors intracellular domain (TβRI-ICD), thereby promoting progression 575 
of prostate cancer cells [71]. Our results might have important implications for the process of 576 
carcinogenesis. ITSN1-s is highly expressed in pancreatic, lung, liposarcomas and Wilm’s tumors, 577 
as shown in ONCOMINE database. Furthermore, ITSN1-s is necessary for malignant glioma cell 578 
proliferation and for in vitro and in vivo tumorigenic properties of primary human neuroblastoma 579 
tumors [72, 73]. It is evident that ITSN1-s plays a critical role in this process due to its tertiary 580 
structure, allowing its domains to make contacts with many specific targets. Furthermore, its role in 581 
tumorigenesis has been linked to signaling regulation rather than endocytosis although the signaling 582 
pathways involved have only been started to be unveiled.  583 
In conclusion, our results suggest a new scenario that foresees the nucleocytoplasmic 584 
shuttling of ITSN1-s as an important clue for understanding the physiological and disease-related 585 
role of this scaffold protein. 586 
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FIGURE LEGENDS 794 
 795 
Fig. 1 A fraction of endogenous and overexpressed ITSN1-s localizes within the cell nucleus. 796 
(A) HeLa cells, untransfected or transfected to express FLAG-ITSN1-s, were processed for nucleus 797 
(N)/cytosol (C) separation and the obtained fractions subjected to SDS-PAGE/WB using the 798 
indicated antibodies. The image is representative of three independent experiments. (B) HeLa cells 799 
transfected to express FLAG-ITSN1-s were fixed with PFA and processed for CLSM as described 800 
in the Experimental section. The DAPI channel, depicting cell nuclei is shown on the left panel, the 801 
FITC channel, relative to FLAG-ITSN1-s is shown on the middle panel, whereas a merged image of 802 
both channels is shown on the right panel. Scale bars, 5 μm. The inset represent a 1,5X 803 
magnification of the boxed area. 804 
 805 
Fig. 2 Nuclear ITSN1-s is associated with the nuclear envelope. (A) 48 h after being transfected 806 
to express FLAG-ITSN1-s, HeLa cells were lysed and processed as described in the Experimental 807 
section to obtain whole cell lysate (W), cytosol (C), nuclei (N), nucleoplasm (NP) and nuclear 808 
envelope (NE) fractions. The respective distribution of the indicated proteins was investigated by 809 
SDS-PAGE/WB using the indicated antibodies, as described in the Experimental section. The 810 
amounts loaded were W 10%, C 30%, N 5%, NP 25%, NE 25% of the total cell extracts, 811 
respectively. The image is representative of three independent experiments. (B) FLAG-ITSN1-s 812 
transfected HeLa cells were fixed with 4% PFA, and processed for IF as described in the 813 
Experimental section to allow detection of FLAG-ITSN1-s (left panel), lamin A/C (middle panel), 814 
cell nuclei (DAPI, right panel). A merged image of all channels is shown on the right. Scale bars, 815 
5 μm. The inset represents a 1,5 X magnification of the boxed area. Shown is a representative 816 
image chosen among three independent experiments. (C) HeLa cells were harvested, and 500 μg 817 
of the whole cell lysates were immunoprecipitated either in the presence of the α-ITSN1-s 818 
endogenous, α-lamin A/C or in the absence (k-) of antibodies, as described in the Experimental 819 
section. After SDS-PAGE/WB, purified proteins were detected using α-ITSN endogenous or α-820 
lamin A/C antibodies. Whole cell lysates [50 μg (I)] were also loaded as further reference. The 821 
image is representative of three independent experiments. 822 
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 (D) HeLa cells were treated with PFA 1% and processed to obtain a homogenate fraction (H, 50 823 
μg) and DNA protein complexes (DPC, 10 cm dish content) as described in the Experimental 824 
section. Fractions were analyzed by SDS-PAGE/WB using the α-ITSN endogenous, α-tubulin and 825 
α-histone H3 (H3) antibodies. The image is representative of three independent experiments. 826 
 827 
Fig. 3 ITSN1-s contains several putative NTSs. The primary sequences of ITSN1-s (NCBI 828 
Accession Number: NP_001001132.1) was scanned for putative NLS and NES using different 829 
bioinformatics tools, as described in the Experimental section. (A) A graphic representation of 830 
ITSN1s multi-domain structure is shown, along with the respective position of putative NLS 831 
(NLS; gray oval), and NESs (A-F; blue stars). Epsin-like domains (EH; orange ovals). Coiled coil 832 
domain (CC; red square). Src-Homology 3 domains (SH3; green hexagons). (B) The sequence of 833 
each putative NLS and NES is shown, along with the method used for their identification and a 834 
color code, indicating the position with respect to ITSN1-s domains identical to that used in panel 835 
a. The single letter amino acid code is used. Basic residues forming the putative NLS are in bold 836 
face. Hydrophobic residues forming putative NESs are underlined. 837 
 838 
Fig. 4 ITSN1-s interacts with IMPD(A) HEK 293-T cells were transfected to express GFP-839 
IMPD'IBB in the presence of FLAG-UL44. Cells were harvested 48 h after transfection and 500 840 
μg of whole cell lysates were immunoprecipitated either in the presence (FLAG) or in the absence 841 
(k-) of the α-FLAG mAb, as described in the Experimental section. Whole cell lysates [50 μg (I)], 842 
and immunoprecipitated proteins (IP) were separated by SDS-PAGE/WB and the presence of the 843 
indicated proteins revealed using either D-FLAG or D-GFP mAbs. (B) HEK 293-T cells were 844 
transfected to express GFP-IMPD'IBB in the presence of (+), or in the absence (-) of FLAG-845 
ITSN1-s. Cells were harvested 48 h after transfection and 1 mg of transfected cell lysates was 846 
immunoprecipitated in the presence of the α-FLAG mAb, as described in the Experimental 847 
section. Whole cell lysates [50 μg (I)] and immunoprecipitated proteins (IP-FLAG) were separated 848 
by SDS-PAGE/WB, and purified proteins were detected using either D-FLAG or D-GFP mAbs 849 
The image is representative of three independent experiments. 850 
 851 
Fig. 5 ITSN1-s shuttles between nucleus and cytoplasm in a CRM-1 dependent fashion. HeLa 852 
cells were transfected to transiently express FLAG-ITSN1-s. Eight hours before processing samples 853 
for IF and CLSM analysis, cells were treated either with LMB (2.9 ng/μl 0.01% Methanol) or with 854 
solvent (0.01% Methanol). (A) Representative microscopic images of cells treated with solvent (- 855 
LMB; top panels), or LMB (+ LMB; bottom panels) are shown relative to ITSN1s (first panels), 856 
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lamin A/C (second panels) and nuclei (DAPI, third panels). A merged image is shown (right 857 
panels). Scale bars, 5 μm. (B) Digital images such as those shown in (A) were quantitatively 858 
analyzed using software ImageJ to calculate the Fn/c ratio relative to ITSN1-s, as described in the 859 
Experimental section. The mean ± SEM relative to at least three independent experiments (n ≥3) is 860 
shown, along with the p value relative to the Student t-test between LMB treated and untreated 861 
cells. ** = p ≤ 0.01 862 
 863 
Fig. 6 ITSN1-s CC and SH3 regions can independently undergo nucleocytoplasmic shuttling. 864 
(A) HEK 293 cells were transfected to transiently express the indicated YFP-ITSN1-s fusion 865 
proteins. The presence of the putative NLS (NLS; gray oval), and NESs (A-F; blue stars) is 866 
indicated. (B) 48 h post transfections cells were lysed and processed as described in the 867 
Experimental section for SDS-PAGE/WB analysis, to allow detection of the indicated fusion 868 
protein using a polyclonal α-GFP antibody. The presence of the YFP-ITSN1-s fusion of interest at 869 
the expected molecular weight is indicated by a pink arrowhead, whereas the presence of YFP-870 
ITSN-CC aggregates of higher molecular weight is highlighted by black arrowheads. The image is 871 
representative of three independent experiments. (C) Eight hours before being processed for 872 
imaging by CLSM, cells were treated with either LMB (2.9 ng/μl 0.01% Methanol) or solvent 873 
(0.01% Methanol). Representative microscopic images of cells treated with solvent (- LMB; top 874 
panels), or LMB (+ LMB; bottom panels) are shown. Scale bars, 10 μm (D) Digital images such 875 
as shown in (C) were quantitatively analyzed using software ImageJ to calculate the Fn/c ratio 876 
relative to the indicated proteins, as described in the Experimental section. The mean ± SEM 877 
relative to at least three independent experiments is shown, along with the p value relative to the 878 
Student t test between LMB treated and untreated cells. * = p ≤ 0.05  879 
 880 
Fig. 7 ITSN1-s residues 1104-1127 represent a bipartite cNLS able to confer energy 881 
dependent nuclear targeting properties to heterologous proteins. (A) HEK 293-A cells were 882 
transfected to transiently express the indicated fusion proteins. Thirty min before processing the 883 
cells for CLSM analysis, media was changed either with fresh DMEM (+ ATP, left panels) or with 884 
an energy depletion media (- ATP, right panels; see Experimental section). Scale bars, 10 μm (B) 885 
Digital images such as those shown in (A) were quantitatively analyzed using software ImageJ to 886 
calculate the Fn/c ratio relative to each fusion protein, as described in the Experimental section. 887 
The mean ± SEM relative to pooled data from two independent experiments (n > 40) is shown, 888 
along with the p value relative to the Student t test between cells expressing YFP-NLS fusions and 889 
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YFP alone in the presence of ATP, or relative to cells expressing the individual YFP fusions, in 890 
the presence or in the absence of ATP . * = p ≤ 0.05 891 
 892 
Fig. 8 ISTN-NLS is important for ITSN-SH3 region nuclear accumulation. (A) HEK 293-A 893 
cells were transfected to transiently express the YFP-ITSN1s fusions shown. The presence of the 894 
putative NLS (NLS; gray oval), and NESs (A-F; blue stars) is indicated. Mutated NLS are shown 895 
as black ovals. (B) Six hours before being processed for CLSM analysis, cells were treated with 896 
either LMB (2.9 ng/μl in 0.01% Methanol) or solvent (0.01% Methanol). Representative images 897 
relative to the indicated YFP-ITSN1s point mutant are shown either in the absence (- LMB, upper 898 
panels) or in the presence (+ LMB, bottom panels) of LMB. Scale bars, 10 μm (C) Digital images 899 
such as those shown in (B) were quantitatively analyzed using software ImageJ to calculate the 900 
Fn/c ratio relative to each fusion protein, as described in the Experimental section. The mean ± 901 
SEM relative to at least three independent experiments is shown, along with the p value relative to 902 
the Student t test between the indicated conditions. * = p ≤ 0.05 903 
 904 
 905 
Fig. 9 ITSN1s-CC possesses an intrinsic capability to undergo nucleocytoplasmic shuttling.  906 
(A) HEK 293-A cells were transfected to transiently express the YFP-ITSN1-s fusions shown. The 907 
presence of the putative NLS (NLS; gray oval), and NESs (A-F; blue stars) is indicated. Mutated 908 
NLS are shown as black ovals. (B) Six hours before being processed for CLSM analysis, cells were 909 
treated with either LMB (2.9 ng/μl 0.01% Methanol) or solvent (0.01% Methanol). Representative 910 
images relative to the indicated YFP-ITSN1s point mutant are shown either in the absence (- LMB; 911 
upper panels) or in the presence (+ LMB; bottom panels) of LMB. Scale bars, 10 μm (C) Digital 912 
images such as those shown in (B) were quantitatively analyzed using software ImageJ to calculate 913 
the Fn/c ratio relative to each fusion protein, as described in the Experimental section. The mean ± 914 
SEM is shown (n > 3), along with the p value relative to the Student t test between LMB treated and 915 
untreated cells. * = p ≤ 0.05 916 
 917 
 918 
Fig. S1 GFP-fusion proteins were used as controls for LMB treatment. (A) HeLa cells were 919 
transfected to transiently express GFP, GFP-REV or GFP-UL44. Eight hours before processing 920 
samples for IF and CLSM analysis, cells were treated either with LMB (2.9 ng/μl 0.01% Methanol) 921 
or with solvent (0.01% Methanol). Representative microscopic images of cells treated with solvent 922 
(- LMB; top panels), or LMB (+ LMB; bottom panels) are shown relative to different constructs. A 923 
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merged image, including DAPI staining to facilitate visualization of cell nuclei is shown (right 924 
panels). (B) Digital images such as shown in (A) were quantitatively analyzed using software 925 
ImageJ to calculate the Fn/c ratio relative to GFP and GFP-fusions, as described in the 926 
Experimental section. The mean ± SEM relative to at least three independent experiments (n ≥ 3) is 927 
shown. The p value relative to the Student t-test between LMB treated and untreated cells is shown. 928 
*** = p ≤ 0.001 929 
 930 
Fig S2. YFP-ITSN1-s allows direct visualization of ITSN1-s in living cells. HeLa cells were 931 
transfected to transiently express YFP-ITSN1-s and imaged live for 30 min using a Leica DMi8 932 
inverted epifluorescent microscope. Images relative to Bright field and nuclei (not shown) as well 933 
as of the YFP channel (gray) were acquired every minute. Scale bars, 20 mM. Positions of a large 934 
(red arrow) and small (green arrow) ITSN1-s vesicles is shown. 935 
 936 
Fig. S3. Time dependent nuclear accumulation of YFP-ITSN1-s in the nucleus of living cells 937 
upon addition of LMB. HeLa cells were transfected to transiently express YFP-ITSN1-s. 15 min 938 
after addition of LMB or vehicle, the subcellular localization of spontaneously fluorescent fusion 939 
proteins was monitored for 10h with a frequency of 15 min using a Leica DMi8 inverted 940 
epifluorescent microscope. (A) The subcellular localization of a cell expressing YFP-ITSN1-s is 941 
shown, along with the time after addition of LMB. (B) Quantification of the levels of nuclear 942 
accumulation of YFP-ITSN1-s at the indicated time points after the addition of LMB (red circles) 943 
or vehicle (blue circles). Data are the mean + standard error of the mean relative to > 5 cells. (C) 944 
Quantification of the levels of nuclear accumulation YFP-ITSN1-s (red circles) of the control fusion 945 
protein GFP-UL44DNLS (blue circles) at the indicated time points after addition of LMB. Data are 946 
the mean ± SEM relative to > 5 cells. 947 
 948 
Movie S1. YFP-ITSN1-s allows direct visualization of ITSN1-s in living cells. HeLa cells were 949 
transfected to transiently express YFP-ITSN1-s and imaged live for 30 min using a Leica  DMi8 950 
inverted microscope. Images relative to Bright field and nuclei (not shown) as well as of the YFP 951 
channel (gray) were acquired every minute. Scale bars, 20 mM. Positions of a large (red arrow) and 952 
small (green arrow) ITSN1-s vesicles is shown. 953 
 954 
Movie S2. Time dependent nuclear accumulation of YFP-ITSN1-s in the nucleus of living cells 955 
upon addition of LMB. HeLa cells were transfected to transiently express YFP-ITSN1-s. 15 min 956 
after addition of LMB or vehicle, the subcellular localization of spontaneously fluorescent fusion 957 
28 
 
proteins was monitored for 10h with a frequency of 15 min using a Leica DMi8 inverted 958 
epifluorescent microscope. The subcellular localization (top panels) and relative Fn/c quantification 959 
(bottom panels) relative to cells expressing YFP-ITSN1-s either in the absence (left panels) or 960 
presence (midldle panels) of LMB, as well as to cells expressing GFP-UL44DNLS after addition of 961 
LMB (right panels) is shown. Data are the mean ± SEM relative to > 5 cells. 962 









Supplementary Table S1, data to Figure S1 
 
 
                      - LMB                       + LMB 
Plasmid mean              S.E.M.             n               mean              S.E.M.             n               
Rev-GFP 0.43 0.1 3 15.47 7.22 3 
GFP UL44'NLS  0.24 0.13 4 0.3 0.07 4 
GFP 1.23 0.1 3 1.53 0.3 3 
 
 
 
Supplementary Table S1. Data to Figure S1. Digital images such as shown in Figure S1, were 
quantitatively analysed using software ImageJ to calculate the Fn/C ratio relative to the indicated 
proteins, as described in Material and Method section. For each experiment, an average of 30 cells 
was analyzed. The mean, and standard error of the mean (S.E.M.) relative to n experiments are 
shown. 
 
  
Supplementary Table S2, data to Figure 5 
 
 
                       - LMB                       + LMB 
Plasmid mean              S.E.M.             n               mean              S.E.M.              n               
FLAG-ITSN1-s 0.17 0.02 3 0.43 0.02 3 
       
       
 
Supplementary Table S2. Data to Figure 5. Digital images such as shown in Figure 5 were 
quantitatively analysed using software ImageJ to calculate the Fn/C ratio relative to the indicated 
proteins, as described in Material and Method section. For each experiment, an average of 30 cells 
was analyzed. The mean, and standard error of the mean (S.E.M.) relative to n experiments are 
shown. 
  
Supplementary Table S3, data to Figure 6d, left panels 
 
 
                      - LMB                       + LMB 
Plasmid mean              S.E.M.                 n               mean              S.E.M.                  n               
Rev-GFP 0.16 0.06 8 19.31 4.00 7 
GFP/YFP 1.27 0.05 7 1.50 0.11 6 
GFP UL44'NLS 0.10 0.04 4 0.17 0.05 3 
 
 
 
Supplementary Table S3. Data to Figure 6d, left panels. Digital images such as shown in 
Figure 6c, left panel, were quantitatively analysed using software ImageJ to calculate the Fn/C ratio 
relative to the indicated proteins, as described in Material and Method section. For each experiment, 
an average of 30 cells was analyzed. The mean, and standard error of the mean (S.E.M.) relative to 
n experiments are shown. 
 
 
 
  
 
Supplementary Table S4, data to Figure 6d, right panels 
 
                       - LMB                      + LMB 
YFP-ITSN1-s  mean              S.E.M. n mean              S.E.M. n 
[1-1220] 0.11 0.03 7 0.41 0.04 6 
[316-1220] 0.07 0.02 4 0.32 0.06 3 
[1-680] 0.42 0.05 4 1.32 0.09 3 
[1-315] 1.13 0.16 5 1.34 0.18 3 
[316-680] 0.24 0.04 5 0.72 0.07 4 
[681-1220] 0.10 0.01 9 0.78 0.09 8 
 
Supplementary Table S4. Data to Figure 6d, right panels. Digital images such as shown in 
Figure 6c, right panel, were quantitatively analysed using software ImageJ to calculate the Fn/C 
ratio relative to the indicated proteins, as described in Material and Method section. For each 
experiment, an average of 30 cells was analyzed. The mean, and standard error of the mean 
(S.E.M.) relative to n experiments are shown. 
 
 
 
 
  
Supplementary Table S5, data to Figure 7b 
 
 
Supplementary Table S5. Data to Figure 7b. Digital images such as shown in Figure 7a, were 
quantitatively analysed using software ImageJ to calculate the Fn/C ratio relative to the indicated 
proteins, as described in Material and Method section. Data from two independent experiments 
were pooled. The mean and standard error of the mean (S.E.M.) relative the indicated number of 
cells are shown.  
 
  
 YFP YFP-ITSN-1s-NLS YFP-NLS[R] 
+ ATP - ATP + ATP - ATP + ATP - ATP 
Number of cells 215 105 104 52 83 43 
Mean 1.110 1.179 1.830 1.351 2.810 1.469 
S.E.M. 0.02 0.03 0.07 0.05 0.18 0.09 
Supplementary Table S6, data to Figure 8c 
 
 
                               - LMB                        + LMB 
YFP-ITSN1-s  mean              S.E.M. n mean              S.E.M. n 
[1-1220] 0.11 0.03 7 0.41 0.04 6 
[1-1220]-'NLS 0.18 0.03 3 0.39 0.03 3 
[681-1220] 0.10 0.01 9 0.78 0.09 8 
[681-1220]-' NLS 0.14 0.02 4 0.38 0.06 4 
[681-1137] 0.16 0.02 3 1.14 0.09 3 
[681-1137]-' NLS 0.18 0.09 3 0.50 0.08 3 
[1074-1220] 0.91 0.06 9 1.85 0.04 8 
[1074-1220]-' NLS 0.50 0.04 4 1.48 0.21 4 
 
Supplementary Table S6. Data to Figure 8c. Digital images such as shown in Figure 8b, were 
quantitatively analysed using software ImageJ to calculate the Fn/C ratio relative to the indicated 
proteins, as described in Material and Method section. For each experiment, an average of 30 cells 
was analyzed. The mean, and standard error of the mean (S.E.M.) relative to n experiments are 
shown. 
  
Supplementary Table S7, data to Figure 9c 
 
Supplementary Table S7. Data to Figure 9c. Digital images such as shown in Figure 9b, were 
quantitatively analysed using software ImageJ to calculate the Fn/C ratio relative to the indicated 
proteins, as described in Material and Method section. For each experiment, an average of 30 cells 
was analyzed. The mean, and standard error of the mean (S.E.M.) relative to n experiments are 
shown. 
 
                            - LMB                        + LMB 
YFP-ITSN1-s  mean              S.E.M              n mean              S.E.M. n 
[316-680] 0.24 0.04 5 0.72 0.07 4 
[316-456] 0.65 0.02 5 1.37 0.10 4 
[316-456]-mNESD 0.57 0.03 5 1.37 0.06 4 
[461-680] 0.29 0.04 4 1.07 0.14 3 



